Psy114 - Cost-Effectiveness of Vedolizumab Compared With Conventional Therapy in Patients With Crohn’s Disease in the United Kingdom (Uk)

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2689
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search